Key Takeaways:
Amgen Inc. (AMGN) on Tuesday reported first-quarter earnings of $5.15 per share, surpassing analyst estimates of $4.73 and delivering a 5.1 percent increase from a year earlier.
The results provided a boost to the Dow Jones Industrial Average, where Amgen was one of the larger components helping lift the index more than 750 points on the day, according to market data from Yahoo Finance.
The pharmaceutical giant's performance showed a notable beat on profitability expectations, though revenue figures were not immediately disclosed.
Amgen's earnings beat lands in a market that has seen the S&P 500 and Nasdaq Composite notch record highs, capping the best month for stocks since November 2020. The rally has been largely fueled by a boom in artificial intelligence spending, which has lifted technology giants like Alphabet and Amazon after their own strong earnings reports.
However, the healthcare sector has not broadly participated in the rally, with the Health Care Select Sector SPDR Fund (XLV) tracking lower for the month. Amgen's positive results may offer a bright spot for the sector. The company's year-over-year earnings growth of 5.1 percent, from $4.90 per share in the year-ago quarter, demonstrates underlying strength despite the sector-wide headwinds.
The positive earnings surprise is likely to increase investor confidence in Amgen. Investors will be watching for the company's full earnings call and updated guidance to assess the outlook for the rest of the year.
This article is for informational purposes only and does not constitute investment advice.
